Adverse events following pandemic XXXX vaccine Pandemrix   reported in the French military forces--2009-2010.

@entity1 @entity410 @entity137 @entity683 @entity5011
BACKGROUND: In the face of the A(H1N1) 2009 @entity683 pandemic, in October 2009 the French military health service (SSA) initiated a large vaccination campaign with Pandemrix(  ) vaccine in the military forces. The aim of this study was to describe @entity137 ( @entity137 ) reported during this campaign. METHODS: @entity137 and the number of @entity1 vaccinated were surveyed by the SSA Epidemiological network across all military forces during the campaign, from October 2009 to April 2010. For each case, a notification form was completed, providing @entity1 and clinical information. Three types of @entity137 were considered: non-serious, serious and unexpected. RESULTS: There were 315.4 reported @entity137 per 100,000 vaccinations. Vaccination and @entity137 incidence rate peaks coincided with @entity683 peak in early December. The number of injected doses was 49,138, corresponding to a 14.5% vaccination coverage among military personnel, and 155 @entity137 were reported, including 5 serious @entity137 (1 @entity5011 , 2 malaises and 1 @entity410 episode). Most @entity137 were non-serious (97.1%). Among these, 6 cases of local, rapidly regressive paresthesia were observed. DISCUSSION: The military @entity137 surveillance system constitutes the only observatory on benign @entity137 in France. The reporting rate was much higher after the pandemic vaccine than after the seasonal vaccine, which may be a reflection of stimulated reporting. This report provides a useful description of @entity137 among military personnel during a mass emergency vaccination program, showing that the tolerance of the pandemic vaccine appeared acceptable.
